Although the PGRMC1–TMEM97–LDLR protein complex could be a potential diagnostic or therapeutic target, little is known about the in vivo expression of these proteins in subtypes of human breast cancer or their association with clinical outcomes. Here, PGRMC1 is linked to breast cancer.